| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 02/12/2003 | EP1282610A1 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments |
| 02/12/2003 | EP1282602A1 Propanoic acid derivatives as integrin receptor antagonists |
| 02/12/2003 | EP1282592A2 Use of amines |
| 02/12/2003 | EP1282445A2 N-substituted dithiocarbamates for the treatment of biological disorders |
| 02/12/2003 | EP1282436A2 Treatment of acute coronary syndrome with glp-1 |
| 02/12/2003 | EP1282435A2 Interleukin-1 inhibitors in the treatment of diseases |
| 02/12/2003 | EP1282431A1 Phytotherapeutic composition for preventing cardiovascular diseases |
| 02/12/2003 | EP1282429A1 Pharmaceutical gel composition |
| 02/12/2003 | EP1282426A1 Nutritional preparation comprising ribose and folic acid and medical use thereof |
| 02/12/2003 | EP1282416A2 Dehydroascorbic acid formulations and uses thereof |
| 02/12/2003 | EP1282410A2 Novel medical use of aldosterone synthase inhibitors alone or in combination with at1-receptor antagonists |
| 02/12/2003 | EP1282366A2 Compositions containing folic acid and reduced folate |
| 02/12/2003 | EP1226239A4 Methods of producing differentiated progenitor cells and lineage-defective embryonic stem cells |
| 02/12/2003 | EP1189899B1 Pyrazinone thrombin inhibitors |
| 02/12/2003 | EP1140984B1 Selective inhibitors of mmp-12 |
| 02/12/2003 | EP1064262B1 Substituted isoindolones and their use as cyclic gmp modulators in medicaments |
| 02/12/2003 | EP1003542B1 Use of substances having oxytocin activity for preparation of medicaments for wound healing |
| 02/12/2003 | EP0969877B1 Methods for the modulation of the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 02/12/2003 | EP0944601B1 Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| 02/12/2003 | EP0889690B1 Antibiotic cocktail and method of use |
| 02/12/2003 | EP0871623B1 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists |
| 02/12/2003 | EP0828488B1 Isothiazolones |
| 02/12/2003 | EP0728147B1 Receptor specific atrial natriuretic peptides |
| 02/12/2003 | EP0614463B1 Angiostatic steroids |
| 02/12/2003 | CN1396930A Devivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect |
| 02/12/2003 | CN1396921A Pyrrolo-isoquinoline and tetrahydropyrrolo-isoquinoline derivatives and their use as mediators of 5-HT7 reactor |
| 02/12/2003 | CN1396915A Heterocylic derivative, its preparation method and medicine composition containing them |
| 02/12/2003 | CN1396909A Inhibitors of ICE/ced-3 family of cysteine protease |
| 02/12/2003 | CN1396908A Palatable arginine compounds and uses thereof for cardiovascular health |
| 02/12/2003 | CN1396833A Integrin expression inhibitors |
| 02/12/2003 | CN1396829A New drug combinations |
| 02/12/2003 | CN1396825A Composition, kit for benefitting cardiovasaclaire and method |
| 02/12/2003 | CN1396823A Electrospun pharmaceutical compositions |
| 02/12/2003 | CN1396254A Formula of dietotherapeutic wine for regulating functions of human body |
| 02/12/2003 | CN1396155A Garlicin extracted reversely by supercritical CO2 and process for preparing its injection |
| 02/12/2003 | CN1395964A Medical usage of simonder wood oil |
| 02/12/2003 | CN1395953A Medicine for treating vasculitis and its preparing process |
| 02/12/2003 | CN1395950A Tea for lowering blood pressure and elongating life and its preparing process |
| 02/12/2003 | CN1395939A Compound of solanesol and its preparing process |
| 02/12/2003 | CN1395935A Citicoline sodium injection for intravenous injection and its preparing process |
| 02/12/2003 | CN1395933A Medicine for treating cardiovascular and cerebrovascular diseases |
| 02/12/2003 | CN1395923A Application of xanthiphenylketamine or its salt in preparing medicines to treat cardiovascalar disease |
| 02/12/2003 | CN1395922A Theopolyphenol composition for injection and its preparing process |
| 02/12/2003 | CN1101384C Process for preparing 1-biphenylmethylmidazole derivatives |
| 02/12/2003 | CN1101228C Treatment of conditions and disease |
| 02/12/2003 | CN1101188C use of green porphyrins in manufacture of medicament in treatment of atherosclerosis without purposeful irradiation of porphyrin derivatives |
| 02/12/2003 | CN1101186C Broiler ascites preventive agent and method of preventing ascites |
| 02/12/2003 | CN1101181C Haemorrhoidal compositions and method of use |
| 02/11/2003 | US6518450 Guaiacoxypropanolamines with alpha/beta adrenergic blocking activity |
| 02/11/2003 | US6518436 Process for preparing pharmacologically acceptable salt of n-(1(s)-ethoxycarbonyl-3-phenylpropyl)-L-alanyl-amino acid |
| 02/11/2003 | US6518432 The invention relates to a novel process for the preparation of certain pharmaceutically active pyridyl compounds. NMDA receptor antagonist activity. The compound known as (S)-1-phenyl-2-(2- pyridyl)ethanamine is of particular |
| 02/11/2003 | US6518429 Anticancer agents, treating restenosis, atherosclerosis and hepatitis virus |
| 02/11/2003 | US6518421 Process for the preparation of epothilone analogs |
| 02/11/2003 | US6518412 Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| 02/11/2003 | US6518310 Non-peptidic; inhibits trypsin-like protease, thrombin and embolus formation; anticoagulant |
| 02/11/2003 | US6518301 Better selectivity than estrogen for the estrogen receptor-beta over receptor-alpha; treatment of Alzheimer's disease, anxiety, depression, osteoporosis, cardiovascular disease, rheumatoid arthritis, or prostate cancer |
| 02/11/2003 | US6518300 Antiplipemic agent, anticholesterol agents |
| 02/11/2003 | US6518294 Fused pyrazolyl compounds |
| 02/11/2003 | US6518292 Heterocyclic aromatic compounds usefuls as growth hormone secretagogues |
| 02/11/2003 | US6518291 Inosine-5'-monophosphate dehydrogenase inhibitors |
| 02/11/2003 | US6518290 Substituted oxazoles and thiazoles derivatives as HPPAr alpha activators |
| 02/11/2003 | US6518288 Amlodipine fumarate |
| 02/11/2003 | US6518287 Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists |
| 02/11/2003 | US6518286 Compounds |
| 02/11/2003 | US6518279 Cyclopentanone dihydropyridine compounds useful as potassium channel openers |
| 02/11/2003 | US6518277 Disrupting leukocyte function |
| 02/11/2003 | US6518274 Use of cyclopentabenzofuran-derivatives for combating (NF-κB)-dependent diseases |
| 02/11/2003 | US6518264 For treatment/prevention of psychoses, other brain disorders, and cardiovascular disorders |
| 02/11/2003 | US6518258 6-sulphamoyl -3-quinolyphosphonic acid compounds |
| 02/11/2003 | US6518255 Administering, via multiple applications to target tissue, a dose of an adenoviral vector comprising a DNA encoding an angiogenic peptide which is an endothelial growth factor and a carrier to increase level of perfusion of blood to target |
| 02/11/2003 | US6518251 Macrolides |
| 02/11/2003 | US6518245 Treatment of arrhythmias via inhibition of a multifunctional calcium/calmodulin-dependent protein kinase |
| 02/11/2003 | US6518239 Dry powder compositions having improved dispersivity |
| 02/11/2003 | US6518062 Enzyme combinations for destroying proliferative cells |
| 02/11/2003 | US6517871 Amorphous ammonium salt; blocking angiotensin II receptors; treating hypertension, congestive heart failure and renal failure |
| 02/11/2003 | US6517843 Recombinant immunogen comprised of an inactivated porcine circovirus-2 |
| 02/11/2003 | CA2205274C Novel 2,3 disubstituted-(5,6)-heteroarylfused-pyrimidine-4-ones |
| 02/11/2003 | CA2174529C Dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5) and uses thereof |
| 02/11/2003 | CA2092305C Compounds having antihypertensive and anti-ischemic properties |
| 02/10/2003 | WO2002014320A2 Novel substituted diaryl azepine derivatives as integrin ligands |
| 02/10/2003 | CA2419078A1 Substituted diaryl azepine derivatives as integrin ligands |
| 02/07/2003 | CA2354743A1 Mitochondrially targeted antioxidants |
| 02/06/2003 | WO2003010315A1 Abca7 splicing variant |
| 02/06/2003 | WO2003010314A2 Gmg-2 polynucleotides and polypeptides and uses thereof |
| 02/06/2003 | WO2003010303A1 Methods of inducing differentiation of stem cells |
| 02/06/2003 | WO2003010298A1 'probiotic lactobacillus salivarius strains |
| 02/06/2003 | WO2003010297A1 Probiotic bifidobacterium strains |
| 02/06/2003 | WO2003010286A2 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 02/06/2003 | WO2003010284A2 Antisense modulation of c-reactive protein expression |
| 02/06/2003 | WO2003010281A2 Protein kinase inhibitors comprising atp mimetics conjugated to peptides or peptidomimetics |
| 02/06/2003 | WO2003010167A1 8-methoxy-(1,2,4)triazolo(1,5-a)pyridine derivatives and their use as adenosine receptor ligands |
| 02/06/2003 | WO2003010164A1 Arylsulfonamide derivatives as c-jun-n-terminal kinases (jnk's) inhibitors |
| 02/06/2003 | WO2003010159A1 Piperidine derivatives as nmda receptor antagonists |
| 02/06/2003 | WO2003010152A1 Novel crystal of arylethenesulfonamide derivative and process for producing the same |
| 02/06/2003 | WO2003010150A1 Polymorph salt of a pyridazinone derivative for the treatment of arrythmia |
| 02/06/2003 | WO2003010147A1 Acidic quinolone derivatives |
| 02/06/2003 | WO2003010139A2 Antisense modulation of hormone-sensitive lipase expression |
| 02/06/2003 | WO2003010135A1 Novel phenylpropionic acid derivatives |
| 02/06/2003 | WO2003010131A1 Alpha-ketoglutarates of active ingredients and compositions containing same |
| 02/06/2003 | WO2003009897A1 Medicament inhibiting sodium/calcium exchange system |